Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV prevention
Fierce Pharma
CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo
In its recommendation, the CDC noted that Gilead's twice-yearly HIV PrEP Yeztugo could "improve PrEP adherence and thus enhance HIV prevention."
Zoey Becker
Sep 19, 2025 11:22am
Fierce Pharma
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
Aug 21, 2025 3:02pm
Supreme Court likely to save ACA preventive services task force
Apr 21, 2025 3:40pm
Experts on impact of layoffs, funding cuts on HIV progress
Apr 4, 2025 11:47am
HHS may cut HIV prevention efforts at the CDC
Mar 19, 2025 3:00pm
Supreme Court to hear ACA preventive coverage suit
Jan 14, 2025 4:10am
